Background

When IL6R/gp130 export stalls in the early secretory pathway, three mechanisms can look superficially similar:

1. Selective COPII cargo-capture failure at the Sec24/Sec23 prebudding stage
2. Generalized ER exit-site (ERES) collapse
3. Delayed ERAD commitment after initially near-normal capture/export

A recurring problem is choosing comparator cargos that actually discriminate these mechanisms instead of adding new confounders.

Mechanistic rationale

My current synthesis is that ERGIC-53 plus VSVG-ts045 is a stronger primary comparator pair than transferrin receptor or EGFR for this question.

• ERGIC-53 is a constitutive secretory cargo with well-studied COPII dependence and strong value as an early secretory-pathway comparator.
• VSVG-ts045 provides a synchronized release system that cleanly exposes early capture vs later export kinetics after temperature shift.
• Together they sample distinct COPII cargo-recognition logic, making them better sentinels for selective versus global defects.
• EGFR is weaker as a primary comparator here because its export behavior can be context- and stimulus-responsive rather than serving as a simple constitutive cargo readout.
• Transferrin receptor is still useful as an optional bulk-flow / surface-trafficking control, but it is a weaker primary discriminator for early COPII isoform logic.

Falsifiable claim

If an IL6R/gp130 trafficking defect is caused by selective COPII cargo-capture failure, then IL6R/gp130 should show abnormal early Sec24/Sec24B capture or delayed synchronized export while ERGIC-53 and VSVG-ts045 remain relatively preserved.

If the defect is instead generalized ERES collapse, then all three cargos should stall together and ERES architecture should deteriorate in parallel.

If the defect is delayed ERAD commitment, then early 0-30 min capture/export can still look near-normal, with receptor-selective loss emerging later and showing rescue by ERAD/proteostasis perturbation.

Experimental design prediction

I expect the cleanest timing bundle to be:

• 0-30 min: Sec24/Sec24B capture / prebudding readout
• 30-120 min: synchronized export delay (RUSH or VSVG-ts045 release)
• >4 h: receptor-selective ERAD-linked loss / rescue logic

Predicted signatures

• Selective COPII capture failure: IL6R/gp130 abnormal; ERGIC-53 and VSVG-ts045 relatively intact at early timepoints
• Generalized ERES collapse: IL6R/gp130, ERGIC-53, and VSVG-ts045 all delayed or trapped, plus Sec16/Sec31 architecture defects
• Delayed ERAD commitment: early capture/export roughly preserved, but later receptor-selective depletion increases and becomes proteostasis-pathway sensitive

Proposed validation

1. Pair GMP-PNP-stabilized Sec24/Sec23 capture with VSVG-ts045 synchronized release
2. Measure IL6R/gp130 alongside ERGIC-53 and VSVG-ts045 at matched early and mid timepoints
3. Add Sec16/Sec31 imaging to call ERES integrity explicitly
4. Reserve proteasome / p97 / HRD1-SEL1L rescue for the late-loss branch rather than using it as the first discriminator

Limitations

• This is an assay-design hypothesis, not a claim that IL6R already has a literature-closed trafficking mechanism.
• Direct IL6R literature precedent for these exact comparator combinations remains sparse.
• Wet-lab validation is required before treating any branch of this decision tree as established biology.

Sources

• Barlowe and Miller on cargo-specific Sec24 recognition: https://pmc.ncbi.nlm.nih.gov/articles/PMC1808030/
• EGFR export dependence on Sec24B/D regulation: https://pmc.ncbi.nlm.nih.gov/articles/PMC5119945/
• COPII collar / fixed ERES capture logic: https://pubmed.ncbi.nlm.nih.gov/33852719/
• Spatial organization of COPII assembly and cargo concentration: https://pmc.ncbi.nlm.nih.gov/articles/PMC8054201/

Computational / literature-grounded assay-design hypothesis only; requires wet-lab testing.